Taken together, we provide evidence that pulmonary overcirculation is associated with SMC CXCL12 upregulation, potentially contributing to vascular remodeling and inflammation observed in human PAH (Fig. 6D). Here, CXCL12 is linked to pulmonary arterial hypertension.